XML 66 R36.htm IDEA: XBRL DOCUMENT v3.22.2
Business (Details)
treatmentCourse in Millions, $ in Millions
3 Months Ended 6 Months Ended
Sep. 30, 2022
USD ($)
treatmentCourse
Jun. 30, 2022
segment
category
productCandidate
product
Asset Acquisition [Line Items]    
Number of categories of public health threats | category   5
Number of revenue generating products | product   11
Number of product candidates | productCandidate   1
Number of operating segments | segment   2
Forecast    
Asset Acquisition [Line Items]    
Asset acquisition, domestic royalty percentage 20.00%  
Asset acquisition, minimum therapy treatment courses required to earn royalty on future gross profit | treatmentCourse 1.7  
Asset acquisition, international royalty percentage 15.00%  
Chimerix Asset Acquisition | Forecast    
Asset Acquisition [Line Items]    
Payments to acquire productive assets $ 225.0  
Asset acquisition, consideration transferred, contingent consideration 100.0  
Chimerix Asset Acquisition | Milestone Payment One | Forecast    
Asset Acquisition [Line Items]    
Asset acquisition, consideration transferred, contingent consideration 25.0  
Chimerix Asset Acquisition | Milestone Payment Two | Forecast    
Asset Acquisition [Line Items]    
Asset acquisition, consideration transferred, contingent consideration 25.0  
Chimerix Asset Acquisition | Milestone Payment Three | Forecast    
Asset Acquisition [Line Items]    
Asset acquisition, consideration transferred, contingent consideration 25.0  
Chimerix Asset Acquisition | Milestone Payment Four | Forecast    
Asset Acquisition [Line Items]    
Asset acquisition, consideration transferred, contingent consideration 25.0  
Chimerix Asset Acquisition | Regulatory Milestones | Forecast    
Asset Acquisition [Line Items]    
Asset acquisition, consideration transferred, contingent consideration $ 12.5